Search

everythinglearnresearchcommunity

for

Search:↓

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

A 13-year-old with 46 XY DSD had ambiguous genitalia due to incomplete masculinization.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Many women experience sexual dysfunction, but few seek help, and better treatment and medical training are needed.

Breast cancer survivors often face body image and sexual health issues, needing ongoing support and open communication with healthcare providers.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Menopause often leads to lower sexual desire and discomfort during sex, but treatment should be personalized and only if it bothers the woman.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Stem cell treatment improved life quality and sexual function in women with hair loss.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

Finasteride and Dutasteride can improve hair growth in male baldness but may cause temporary sexual dysfunction and possibly affect fertility.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

The review suggests younger men taking 1 mg finasteride report more side effects, including sexual, skin, metabolic, and psychological issues.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

Some drugs may reduce prostatitis symptoms short-term with few side effects.

Delayed ejaculation is a complex issue caused by psychological, biological, and lifestyle factors, requiring a holistic treatment approach.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

BMI is not a significant predictor of complications after gender-affirming penile inversion vaginoplasty.

Women and men experience different quality of life and symptom distress after kidney transplant with immunosuppressive therapy.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Women with PCOS have more emotional and body image issues than healthy women.

The document concludes that proper treatment and management of plaque psoriasis in adolescents can improve their quality of life.

Finasteride can cause lasting sexual, emotional, and cognitive issues, with varying severity.

Testosterone's role in women's sex drive is unclear and needs more research, as low levels don't always mean less sexual interest and high levels can cause side effects.

Finasteride for hair loss can cause long-lasting sexual side effects like low libido and erectile dysfunction.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Finasteride for hair loss may cause persistent sexual symptoms, depression, anxiety, and lower quality of life.